Provides business continuity update regarding COVID-19Continued execution across immuno-neurology platformOn track to initiate pivotal Phase 3 trial of AL001 in […]
NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused […]